Bickling Financial Services, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
Bickling Financial Services, Inc.
- $159 Million
- Q4 2022
A detailed history of Bickling Financial Services, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Bickling Financial Services, Inc. holds 12,082 shares of DNA stock, worth $148,004. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,082
Previous 12,265
1.49%
Holding current value
$148,004
Previous $39,000
48.72%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding DNA
# of Institutions
35Shares Held
48.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY42MShares$515 Million0.0% of portfolio
-
Titleist Asset Management, Ltd. San Antonio, TX2.31MShares$28.3 Million0.92% of portfolio
-
Putnam Investments LLC Boston, MA1.5MShares$18.4 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.15MShares$14 Million0.0% of portfolio
-
Benjamin F. Edwards & Company, Inc. St. Louis, MO235KShares$2.88 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $15.8B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...